Navigation Links
World first: Chinese scientists create pig stem cells
Date:6/2/2009

This release is available in Chinese.

Scientists have managed to induce cells from pigs to transform into pluripotent stem cells cells that, like embryonic stem cells, are capable of developing into any type of cell in the body. It is the first time in the world that this has been achieved using somatic cells (cells that are not sperm or egg cells) from any animal with hooves (known as ungulates).

The implications of this achievement are far-reaching; the research could open the way to creating models for human genetic diseases, genetically engineering animals for organ transplants for humans, and for developing pigs that are resistant to diseases such as swine flu.

The work is the first research paper to be published online today (Wednesday 3 June) in the newly launched Journal of Molecular Cell Biology [1].

Dr Lei Xiao, who led the research, said: "To date, many efforts have been made to establish ungulate pluripotent embryonic stem cells from early embryos without success. This is the first report in the world of the creation of domesticated ungulate pluripotent stem cells. Therefore, it is entirely new, very important and has a number of applications for both human and animal health."

Dr Xiao, who heads the stem cell lab at the Shanghai Institute of Biochemistry and Cell Biology (Shanghai, China), and colleagues succeeded in generating induced pluripotent stem cells by using transcription factors to reprogramme cells taken from a pig's ear and bone marrow. After the cocktail of reprogramming factors had been introduced into the cells via a virus, the cells changed and developed in the laboratory into colonies of embryonic-like stem cells. Further tests confirmed that they were, in fact, stem cells capable of differentiating into the cell types that make up the three layers in an embryo endoderm, mesoder
'/>"/>

Contact: Emma Mason
wordmason@mac.com
44-077-112-96986
Oxford University Press
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Make Sure Your Baby is Seeing the Most Important Things in His World
2. AT&T Shares 2009 NCAA Womens College World Series With American Cancer Society and Boys & Girls Club
3. HDNet World Report Investigates an Alarming String of Murders Committed by Iraq War Veterans
4. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
5. Be a Part of the 1st World MS Day - May 27, 2009
6. World Health Organization Says Health Sector Can Lead the Fight Against Climate Change
7. Worlds First Animatronic Animal Therapy Program Set to Open
8. Singers Mandisa & Jake Owen Help Community Health Organization Set Guinness World Record and Governors Official Proclamation Declared
9. Australian team reveals world-first discovery in a floppy baby syndrome
10. Southern California-Based Shangri La Tea Company Captures Four International Awards at the 2009 World Tea Expo
11. Genomics for a Greener World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)... a phase 1/2 clinical trial that it is ... newly diagnosed with multiple myeloma, a cancer of white ... Cancer Institute. , Partial responses or better were seen ... drug combination in the multi-center study, with 74 percent ... phase 2 population, reports Paul G. Richardson, MD, of ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
(Date:12/5/2009)... new international private medical insurance plan which follows the acclaimed modular ... flexibility to add or remove a wide range of options to ... their benefits to complement those already offered in their country of ... ...
(Date:12/4/2009)... ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: ... has set the regular 2010 Annual Meeting of Stockholders for ... 2009. The meeting will be held at the Crowne Plaza ... 4:30 p.m. PT. ,, The meeting will be webcast by ...
Breaking Medicine News(10 mins):Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2
... study shows weight gain after age 18 can be a ... // are not taking hormone replacement therapy. ,In ... by asking them about their weight at age 18 and ... asked to provide updates on their weight, in addition to ...
... a heart transplant usually lose significant bone mass in the ... powerful drugs that keep their bodies from rejecting the new ... Studies suggest the prevalence of fractures among this group ranges ... a primary goal of treatment, but which drugs work best ...
... suggest that kids who struggle to breathe during sleep ... out. ,Adenotonsillectomy is a common surgical procedure in ... performed to treat recurring bouts of tonsillitis. During the ... to treat obstructive sleep apnea (OSA), a condition in ...
... Testicular cancer usually strikes men between 20 and 34 ... led to an improved survival rate from the cancer, ... young, concern about the effect of the cancer and ... studies have suggested treatment reduces fertility, others have found ...
... that a chemotherapy regimen combining vinorelbine (Navelbine) and mitoxantrone ... treatment of hormone-refractory prostate cancer . Specialists say this ... their disease. , However researchers added that ... is planned. From a group of 66 patients who ...
... deadly condition caused by the heart's inability to pump efficiently.//It ... An estimated 5 million Americans have the condition, which will ... caused by high blood pressure, valve disease, clogged arteries or ... was seen that heart failure patients who took statins ( ...
Other Medicine News:Health News:A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer 2
(Date:12/4/2009)... Technologies, Inc., developers of the AcceleDent System ... orthodontics, announced the availability of a new Continuing ... a leader in professional education for many industries, ... on patient views about orthodontic treatment, a summary ...
(Date:12/4/2009)... (NYSE: AZN ) today announced that the ... SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive ... Disorder (MDD). SEROQUEL XR is the only medication in ... major depressive disorder as adjunctive therapy and acute depressive ...
(Date:12/3/2009)... variation that may indicate a patient,s risk of developing ... pharmaceutical therapies or chemicals is one of several medical ... DGX ) will present during the 51st ... December 5-8, 2009, in New Orleans, LA. ,, ...
Breaking Medicine Technology:AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Foreclosures Plunge People Into Depression 54848 1Foreclosures Plunge People Into Depression 54848 2Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 1Miami Area Experienced Fewer Fluctuations in Pharmacy Benefit Enrollment Than Other Florida Markets 54845 2Lagan Increases Productivity of Case Management Workers in the Field 3B Saves Time and Money for Human Services Agencies with Lagan Mobile 28TM 29 54842 1Lagan Increases Productivity of Case Management Workers in the Field 3B Saves Time and Money for Human Services Agencies with Lagan Mobile 28TM 29 54842 2Lagan Increases Productivity of Case Management Workers in the Field 3B Saves Time and Money for Human Services Agencies with Lagan Mobile 28TM 29 54842 3
... May 23 Researchers at the,West Virginia University ... that interfere with absorption of nutrients in patients ... M.D., Section,Chief of Digestive Diseases at WVU., ... that could replace,steroids in treating this chronic condition ...
... Calif., May 22 Epeius Biotechnologies,announced today the promising ... Rexin-G for metastatic breast cancer that is refractory,to conventional ... intra-patient dose-escalations of Rexin-G given i.v. two to,three times ... 2 x 10e11 cfu to 6,x 10e11 cfu per ...
Other Medicine Technology:Research Team Clones Genes Responsible for Amino Acid Absorption 2TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008) 2
For the quantitative in vitro determination of Phenobarbital in human serum....
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: